Company Profiles

driven by the PitchBook Platform

Gamida Cell

Description

Developer of a pipeline of curative cellular and immune treatments for cancer and orphan genetic diseases. The company's pipeline of products is based on its proprietary NAM technology which increases the limited population and the quality of stem and progenitor cells in such a way that the end product is enriched with a therapeutic quantity of these highly functional cells, enabling the development of a pipeline of curative treatments for a wide range of conditions including cancer, genetic hematological diseases such as sickle cell disease and thalassemia, bone marrow failure syndromes such as aplastic anemia and genetic metabolic diseases.

1998

Founded

PRIVATE

Status

51-200

Employees

Later Stage VC

Latest Deal Type

$40M

Latest Deal Amount

$128M

Total Amount Raised

Description

Developer of a pipeline of curative cellular and immune treatments for cancer and orphan genetic diseases. The company's pipeline of products is based on its proprietary NAM technology which increases the limited population and the quality of stem and progenitor cells in such a way that the end product is enriched with a therapeutic quantity of these highly functional cells, enabling the development of a pipeline of curative treatments for a wide range of conditions including cancer, genetic hematological diseases such as sickle cell disease and thalassemia, bone marrow failure syndromes such as aplastic anemia and genetic metabolic diseases.

Website:

www.gamida-cell.com

Ownership Status

Privately Held (backing)

Financing Status

Venture Capital-Backed

Primary Industry

Biotechnology

Other Industries

Other Devices and Supplies

Primary Office

PO Box 34670 Jerusalem 91340Israel +972 (0)2 659 5666
Request a free trial to the PitchBook Platform
You're viewing a free company profile from the PitchBook Platform. To explore Gamida Cell's full profile, request a free trial.

Gamida Cell Valuation and Funding

Request access
Deal TypeDateAmountRaised to DatePost-ValStatusStage

Gamida Cell Investors (16)

Request access
Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
Seat
Contact
Info
AmgenVC-Backed CompanyMinority000 0000000 0000
Auriga PartnersVenture CapitalMinority000 0000000 0000
Biomedical InvestmentsVenture CapitalMinority000 0000000 0000
Bio-Technology GeneralCorporationMinority000 0000000 0000
Clal Biotechnology IndustriesVenture CapitalMinority000 0000000 0000
Amgen VC-Backed Company
Auriga Partners Venture Capital
Biomedical Investments Venture Capital
Bio-Technology General Corporation
Clal Biotechnology Industries Venture Capital

Gamida Cell Executive Team (5)

NameTitleBoard
Seat
Contact
Info
Yael Margolin Ph.DChief Executive Officer, Board Member & President
Naftali BrikashviliChief Financial Officer
Tony PeledChief Scientific Officer, Vice President of Research & Development & Founder
David SnyderVice President, Clinical Development and Regulatory Affairs
Dorit HaratiVice President, Quality Assurance, Manufacturing & Logistics
Yael Margolin Ph.D Chief Executive Officer, Board Member & President
Naftali Brikashvili Chief Financial Officer
Tony Peled Chief Scientific Officer, Vice President of Research & Development & Founder
David Snyder Vice President, Clinical Development and Regulatory Affairs
Dorit Harati Vice President, Quality Assurance, Manufacturing & Logistics

Gamida Cell Board Members (8)

NameRepresentingRoleSinceContact
Info
Boaz LifschitzSelfBoard Member000 0000
Hadar Ron MDIsrael Healthcare VenturesManaging Partner & Executive, Investments000 0000
Julian Adams Ph.DClal Biotechnology IndustriesChief Science Officer & President000 0000
Kenneth MochSelfBoard Member000 0000
Mordechay ZisserSelfBoard Member000 0000
Boaz Lifschitz Board Member Self
Hadar Ron MD Managing Partner & Executive, Investments Israel Healthcare Ventures
Julian Adams Ph.D Chief Science Officer & President Clal Biotechnology Industries
Kenneth Moch Board Member Self
Mordechay Zisser Board Member Self
Request full access to PitchBook